These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 33571502)

  • 1. 7-phenoxytacrine is a dually acting drug with neuroprotective efficacy in vivo.
    Kaniakova M; Korabecny J; Holubova K; Kleteckova L; Chvojkova M; Hakenova K; Prchal L; Novak M; Dolezal R; Hepnarova V; Svobodova B; Kucera T; Lichnerova K; Krausova B; Horak M; Vales K; Soukup O
    Biochem Pharmacol; 2021 Apr; 186():114460. PubMed ID: 33571502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 7-Methoxyderivative of tacrine is a 'foot-in-the-door' open-channel blocker of GluN1/GluN2 and GluN1/GluN3 NMDA receptors with neuroprotective activity in vivo.
    Kaniakova M; Kleteckova L; Lichnerova K; Holubova K; Skrenkova K; Korinek M; Krusek J; Smejkalova T; Korabecny J; Vales K; Soukup O; Horak M
    Neuropharmacology; 2018 Sep; 140():217-232. PubMed ID: 30099049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationships of dually-acting acetylcholinesterase inhibitors derived from tacrine on N-methyl-d-Aspartate receptors.
    Gorecki L; Misiachna A; Damborsky J; Dolezal R; Korabecny J; Cejkova L; Hakenova K; Chvojkova M; Karasova JZ; Prchal L; Novak M; Kolcheva M; Kortus S; Vales K; Horak M; Soukup O
    Eur J Med Chem; 2021 Jul; 219():113434. PubMed ID: 33892271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of Memantine and 6-Chlorotacrine as Novel Multi-Target Compound against Alzheimer's Disease.
    Kaniakova M; Nepovimova E; Kleteckova L; Skrenkova K; Holubova K; Chrienova Z; Hepnarova V; Kucera T; Kobrlova T; Vales K; Korabecny J; Soukup O; Horak M
    Curr Alzheimer Res; 2019; 16(9):821-833. PubMed ID: 30819076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preferential Inhibition of Tonically over Phasically Activated NMDA Receptors by Pregnane Derivatives.
    Vyklicky V; Smejkalova T; Krausova B; Balik A; Korinek M; Borovska J; Horak M; Chvojkova M; Kleteckova L; Vales K; Cerny J; Nekardova M; Chodounska H; Kudova E; Vyklicky L
    J Neurosci; 2016 Feb; 36(7):2161-75. PubMed ID: 26888927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenoxytacrine derivatives: Low-toxicity neuroprotectants exerting affinity to ifenprodil-binding site and cholinesterase inhibition.
    Misiachna A; Svobodova B; Netolicky J; Chvojkova M; Kleteckova L; Prchal L; Novak M; Hrabinova M; Kucera T; Muckova L; Moravcova Z; Karasova JZ; Pejchal J; Blazek F; Malinak D; Hakenova K; Krausova BH; Kolcheva M; Ladislav M; Korabecny J; Pahnke J; Vales K; Horak M; Soukup O
    Eur J Med Chem; 2024 Feb; 266():116130. PubMed ID: 38218127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GluN2B-containing NMDA receptors as possible targets for the neuroprotective and antidepressant effects of fluoxetine.
    Kiss JP; Szasz BK; Fodor L; Mike A; Lenkey N; Kurkó D; Nagy J; Vizi ES
    Neurochem Int; 2012 Jan; 60(2):170-6. PubMed ID: 22197911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pro-cognitive effects of dual tacrine derivatives acting as cholinesterase inhibitors and NMDA receptor antagonists.
    Chvojkova M; Kolar D; Kovacova K; Cejkova L; Misiachna A; Hakenova K; Gorecki L; Horak M; Korabecny J; Soukup O; Vales K
    Biomed Pharmacother; 2024 Jul; 176():116821. PubMed ID: 38823278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitivity of N-methyl-D-aspartate receptor-mediated excitatory postsynaptic potentials and synaptic plasticity to TCN 201 and TCN 213 in rat hippocampal slices.
    Izumi Y; Zorumski CF
    J Pharmacol Exp Ther; 2015 Feb; 352(2):267-73. PubMed ID: 25413830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of nonsynaptic GluN2B-containing NMDA receptors in excitotoxicity: evidence that fluoxetine selectively inhibits these receptors and may have neuroprotective effects.
    Vizi ES; Kisfali M; Lőrincz T
    Brain Res Bull; 2013 Apr; 93():32-8. PubMed ID: 23089362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pathogenic N650K variant in the GluN1 subunit regulates the trafficking, conductance, and pharmacological properties of NMDA receptors.
    Kolcheva M; Ladislav M; Netolicky J; Kortus S; Rehakova K; Krausova BH; Hemelikova K; Misiachna A; Kadkova A; Klima M; Chalupska D; Horak M
    Neuropharmacology; 2023 Jan; 222():109297. PubMed ID: 36341805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple domains in the C-terminus of NMDA receptor GluN2B subunit contribute to neuronal death following in vitro ischemia.
    Vieira MM; Schmidt J; Ferreira JS; She K; Oku S; Mele M; Santos AE; Duarte CB; Craig AM; Carvalho AL
    Neurobiol Dis; 2016 May; 89():223-34. PubMed ID: 26581639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pathogenic S688Y mutation in the ligand-binding domain of the GluN1 subunit regulates the properties of NMDA receptors.
    Skrenkova K; Song JM; Kortus S; Kolcheva M; Netolicky J; Hemelikova K; Kaniakova M; Krausova BH; Kucera T; Korabecny J; Suh YH; Horak M
    Sci Rep; 2020 Oct; 10(1):18576. PubMed ID: 33122756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temperature dependence of N-methyl-D-aspartate receptor channels and N-methyl-D-aspartate receptor excitatory postsynaptic currents.
    Korinek M; Sedlacek M; Cais O; Dittert I; Vyklicky L
    Neuroscience; 2010 Feb; 165(3):736-48. PubMed ID: 19883737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel dimeric acetylcholinesterase inhibitor bis7-tacrine, but not donepezil, prevents glutamate-induced neuronal apoptosis by blocking N-methyl-D-aspartate receptors.
    Li W; Pi R; Chan HH; Fu H; Lee NT; Tsang HW; Pu Y; Chang DC; Li C; Luo J; Xiong K; Li Z; Xue H; Carlier PR; Pang Y; Tsim KW; Li M; Han Y
    J Biol Chem; 2005 May; 280(18):18179-88. PubMed ID: 15710623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GluN2A and GluN2B N-Methyl-D-Aspartate Receptor (NMDARs) Subunits: Their Roles and Therapeutic Antagonists in Neurological Diseases.
    Ladagu AD; Olopade FE; Adejare A; Olopade JO
    Pharmaceuticals (Basel); 2023 Oct; 16(11):. PubMed ID: 38004401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Piroxicam inhibits NMDA receptor-mediated excitotoxicity through allosteric inhibition of the GluN2B subunit: an in silico study elucidating a novel mechanism of action of the drug.
    Mazumder MK; Borah A
    Med Hypotheses; 2014 Dec; 83(6):740-6. PubMed ID: 25459147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic neuroprotection by bis(7)-tacrine via concurrent blockade of N-methyl-D-aspartate receptors and neuronal nitric-oxide synthase.
    Li W; Xue J; Niu C; Fu H; Lam CS; Luo J; Chan HH; Xue H; Kan KK; Lee NT; Li C; Pang Y; Li M; Tsim KW; Jiang H; Chen K; Li X; Han Y
    Mol Pharmacol; 2007 May; 71(5):1258-67. PubMed ID: 17299028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disruption of S2-M4 linker coupling reveals novel subunit-specific contributions to N-methyl-d-aspartate receptor function and ethanol sensitivity.
    Hughes BA; Woodward JJ
    Neuropharmacology; 2016 Jun; 105():96-105. PubMed ID: 26577016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and in vitro characterisation of ifenprodil-based fluorescein conjugates as GluN1/GluN2B N-Methyl-D-aspartate receptor antagonists.
    Dhilly M; Becerril-Ortega J; Colloc'h N; MacKenzie ET; Barré L; Buisson A; Nicole O; Perrio C
    Chembiochem; 2013 Apr; 14(6):759-69. PubMed ID: 23532918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.